APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plasma for Fractionation

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Plasma for Fractionation Market Outlook and Growth Opportunities 2026

2 January 2026198 pages

Choose your research edition.

Industry ResearchPlasma for Fractionation Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasma for Fractionation Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Plasma for Fractionation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasma for Fractionation Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasma for Fractionation Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Plasma for Fractionation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Plasma for Fractionation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Plasma for Fractionation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Plasma for Fractionation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Plasma for Fractionation market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Plasma for Fractionation market include Biotest, BPL, CBPO, CSL, Grifols, Kedrion, LFB Group, Octapharma and Hualan Bio, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Plasma for Fractionation market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Plasma for Fractionation and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Plasma for Fractionation revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Plasma for Fractionation market.

Plasma for Fractionation Segment by Company

Biotest

BPL

CBPO

CSL

Grifols

Kedrion

LFB Group

Octapharma

Hualan Bio

RAAS

Takeda

Plasma for Fractionation Segment by Type

Recovered Plasma

Source Plasma

Plasma for Fractionation Segment by Application

Albumin

Immune Globulin

Coagulation Factor

Others

Plasma for Fractionation Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Plasma for Fractionation status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Plasma for Fractionation key companies, revenue, market share, and recent developments.

3. To split the Plasma for Fractionation breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Plasma for Fractionation market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Plasma for Fractionation significant trends, drivers, influence factors in global and regions.

6. To analyze Plasma for Fractionation competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma for Fractionation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasma for Fractionation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma for Fractionation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Plasma for Fractionation industry.

Chapter 3: Detailed analysis of Plasma for Fractionation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Plasma for Fractionation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Plasma for Fractionation in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Plasma for Fractionation Industry Trends Table 2. Plasma for Fractionation Industry Drivers Table 3. Plasma for Fractionation Industry Opportunities and Challenges Table 4. Plasma for Fractionation Industry Restraints Table 5. Global Plasma for Fractionation Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Plasma for Fractionation Revenue Share by Company (2021-2026) Table 7. Global Plasma for Fractionation Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Plasma for Fractionation Key Company Manufacturing Base & Headquarters Table 9. Global Plasma for Fractionation Company, Product Type & Application Table 10. Global Plasma for Fractionation Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Plasma for Fractionation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Recovered Plasma Table 15. Significant Companies of Source Plasma Table 16. Global Plasma for Fractionation Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Plasma for Fractionation Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Plasma for Fractionation Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Plasma for Fractionation Sales Value Share by Type (2021-2026) Table 20. Global Plasma for Fractionation Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Albumin Table 22. Significant Companies of Immune Globulin Table 23. Significant Companies of Coagulation Factor Table 24. Significant Companies of Others Table 25. Global Plasma for Fractionation Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Plasma for Fractionation Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Plasma for Fractionation Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Plasma for Fractionation Sales Value Share by Application (2021-2026) Table 29. Global Plasma for Fractionation Sales Value Share by Application (2027-2032) Table 30. Global Plasma for Fractionation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Plasma for Fractionation Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Plasma for Fractionation Sales Value Share by Region (2021-2026) Table 33. Global Plasma for Fractionation Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Plasma for Fractionation Sales Value Share by Region (2027-2032) Table 35. Global Plasma for Fractionation Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Plasma for Fractionation Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Plasma for Fractionation Sales Value Market Share by Country (2021-2026) Table 38. Global Plasma for Fractionation Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Plasma for Fractionation Sales Value Market Share by Country (2027-2032) Table 40. Biotest Company Information Table 41. Biotest Business Overview Table 42. Biotest Plasma for Fractionation Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Biotest Plasma for Fractionation Product Portfolio Table 44. Biotest Recent Development Table 45. BPL Company Information Table 46. BPL Business Overview Table 47. BPL Plasma for Fractionation Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. BPL Plasma for Fractionation Product Portfolio Table 49. BPL Recent Development Table 50. CBPO Company Information Table 51. CBPO Business Overview Table 52. CBPO Plasma for Fractionation Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. CBPO Plasma for Fractionation Product Portfolio Table 54. CBPO Recent Development Table 55. CSL Company Information Table 56. CSL Business Overview Table 57. CSL Plasma for Fractionation Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. CSL Plasma for Fractionation Product Portfolio Table 59. CSL Recent Development Table 60. Grifols Company Information Table 61. Grifols Business Overview Table 62. Grifols Plasma for Fractionation Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Grifols Plasma for Fractionation Product Portfolio Table 64. Grifols Recent Development Table 65. Kedrion Company Information Table 66. Kedrion Business Overview Table 67. Kedrion Plasma for Fractionation Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Kedrion Plasma for Fractionation Product Portfolio Table 69. Kedrion Recent Development Table 70. LFB Group Company Information Table 71. LFB Group Business Overview Table 72. LFB Group Plasma for Fractionation Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. LFB Group Plasma for Fractionation Product Portfolio Table 74. LFB Group Recent Development Table 75. Octapharma Company Information Table 76. Octapharma Business Overview Table 77. Octapharma Plasma for Fractionation Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Octapharma Plasma for Fractionation Product Portfolio Table 79. Octapharma Recent Development Table 80. Hualan Bio Company Information Table 81. Hualan Bio Business Overview Table 82. Hualan Bio Plasma for Fractionation Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Hualan Bio Plasma for Fractionation Product Portfolio Table 84. Hualan Bio Recent Development Table 85. RAAS Company Information Table 86. RAAS Business Overview Table 87. RAAS Plasma for Fractionation Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. RAAS Plasma for Fractionation Product Portfolio Table 89. RAAS Recent Development Table 90. Takeda Company Information Table 91. Takeda Business Overview Table 92. Takeda Plasma for Fractionation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Takeda Plasma for Fractionation Product Portfolio Table 94. Takeda Recent Development Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Plasma for Fractionation Product Image Figure 2. Global Plasma for Fractionation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasma for Fractionation Market Size (2021-2032) & (US$ Million) Figure 4. Global Plasma for Fractionation Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Recovered Plasma Image Figure 8. Source Plasma Image Figure 9. Global Plasma for Fractionation Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Plasma for Fractionation Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Plasma for Fractionation Sales Value Share by Type (2021-2032) Figure 12. Albumin Image Figure 13. Immune Globulin Image Figure 14. Coagulation Factor Image Figure 15. Others Image Figure 16. Global Plasma for Fractionation Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Plasma for Fractionation Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Plasma for Fractionation Sales Value Share by Application (2021-2032) Figure 19. Global Plasma for Fractionation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Plasma for Fractionation Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Plasma for Fractionation Sales Value (2021-2032) & (US$ Million) Figure 22. North America Plasma for Fractionation Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Plasma for Fractionation Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Plasma for Fractionation Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Plasma for Fractionation Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Plasma for Fractionation Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Plasma for Fractionation Sales Value (2021-2032) & (US$ Million) Figure 28. South America Plasma for Fractionation Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Plasma for Fractionation Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Plasma for Fractionation Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Plasma for Fractionation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Recovered Plasma
  • Source Plasma
Applications
  • Albumin
  • Immune Globulin
  • Coagulation Factor
  • Others
Companies covered
  • Biotest
  • BPL
  • CBPO
  • CSL
  • Grifols
  • Kedrion
  • LFB Group
  • Octapharma
  • Hualan Bio
  • RAAS
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Plasma for Fractionation Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Plasma for Fractionation Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Plasma for Fractionation Market Dynamics
  1. 2.1 Plasma for Fractionation Industry Trends
  2. 2.2 Plasma for Fractionation Industry Drivers
  3. 2.3 Plasma for Fractionation Industry Opportunities and Challenges
  4. 2.4 Plasma for Fractionation Industry Restraints
3 Plasma for Fractionation Market by Company
  1. 3.1 Global Plasma for Fractionation Company Revenue Ranking in 2025
  2. 3.2 Global Plasma for Fractionation Revenue by Company (2021-2026)
  3. 3.3 Global Plasma for Fractionation Company Ranking (2024-2026)
  4. 3.4 Global Plasma for Fractionation Company Manufacturing Base and Headquarters
  5. 3.5 Global Plasma for Fractionation Company Product Type and Application
  6. 3.6 Global Plasma for Fractionation Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Plasma for Fractionation Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Plasma for Fractionation Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Plasma for Fractionation Market by Type
  1. 4.1 Plasma for Fractionation Type Introduction
  2. 4.1.1 Recovered Plasma
  3. 4.1.2 Source Plasma
  4. 4.2 Global Plasma for Fractionation Sales Value by Type
  5. 4.2.1 Global Plasma for Fractionation Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Plasma for Fractionation Sales Value by Type (2021-2032)
  7. 4.2.3 Global Plasma for Fractionation Sales Value Share by Type (2021-2032)
5 Plasma for Fractionation Market by Application
  1. 5.1 Plasma for Fractionation Application Introduction
  2. 5.1.1 Albumin
  3. 5.1.2 Immune Globulin
  4. 5.1.3 Coagulation Factor
  5. 5.1.4 Others
  6. 5.2 Global Plasma for Fractionation Sales Value by Application
  7. 5.2.1 Global Plasma for Fractionation Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Plasma for Fractionation Sales Value by Application (2021-2032)
  9. 5.2.3 Global Plasma for Fractionation Sales Value Share by Application (2021-2032)
6 Plasma for Fractionation Regional Value Analysis
  1. 6.1 Global Plasma for Fractionation Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Plasma for Fractionation Sales Value by Region (2021-2032)
  3. 6.2.1 Global Plasma for Fractionation Sales Value by Region: 2021-2026
  4. 6.2.2 Global Plasma for Fractionation Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Plasma for Fractionation Sales Value (2021-2032)
  7. 6.3.2 North America Plasma for Fractionation Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Plasma for Fractionation Sales Value (2021-2032)
  10. 6.4.2 Europe Plasma for Fractionation Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Plasma for Fractionation Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Plasma for Fractionation Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Plasma for Fractionation Sales Value (2021-2032)
  16. 6.6.2 South America Plasma for Fractionation Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Plasma for Fractionation Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Plasma for Fractionation Sales Value Share by Country, 2025 VS 2032
7 Plasma for Fractionation Country-level Value Analysis
  1. 7.1 Global Plasma for Fractionation Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Plasma for Fractionation Sales Value by Country (2021-2032)
  3. 7.2.1 Global Plasma for Fractionation Sales Value by Country (2021-2026)
  4. 7.2.2 Global Plasma for Fractionation Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Plasma for Fractionation Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Plasma for Fractionation Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Plasma for Fractionation Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Biotest
  2. 8.1.1 Biotest Company Information
  3. 8.1.2 Biotest Business Overview
  4. 8.1.3 Biotest Plasma for Fractionation Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Biotest Plasma for Fractionation Product Portfolio
  6. 8.1.5 Biotest Recent Developments
  7. 8.2 BPL
  8. 8.2.1 BPL Company Information
  9. 8.2.2 BPL Business Overview
  10. 8.2.3 BPL Plasma for Fractionation Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BPL Plasma for Fractionation Product Portfolio
  12. 8.2.5 BPL Recent Developments
  13. 8.3 CBPO
  14. 8.3.1 CBPO Company Information
  15. 8.3.2 CBPO Business Overview
  16. 8.3.3 CBPO Plasma for Fractionation Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CBPO Plasma for Fractionation Product Portfolio
  18. 8.3.5 CBPO Recent Developments
  19. 8.4 CSL
  20. 8.4.1 CSL Company Information
  21. 8.4.2 CSL Business Overview
  22. 8.4.3 CSL Plasma for Fractionation Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CSL Plasma for Fractionation Product Portfolio
  24. 8.4.5 CSL Recent Developments
  25. 8.5 Grifols
  26. 8.5.1 Grifols Company Information
  27. 8.5.2 Grifols Business Overview
  28. 8.5.3 Grifols Plasma for Fractionation Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Grifols Plasma for Fractionation Product Portfolio
  30. 8.5.5 Grifols Recent Developments
  31. 8.6 Kedrion
  32. 8.6.1 Kedrion Company Information
  33. 8.6.2 Kedrion Business Overview
  34. 8.6.3 Kedrion Plasma for Fractionation Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Kedrion Plasma for Fractionation Product Portfolio
  36. 8.6.5 Kedrion Recent Developments
  37. 8.7 LFB Group
  38. 8.7.1 LFB Group Company Information
  39. 8.7.2 LFB Group Business Overview
  40. 8.7.3 LFB Group Plasma for Fractionation Revenue and Gross Margin (2021-2026)
  41. 8.7.4 LFB Group Plasma for Fractionation Product Portfolio
  42. 8.7.5 LFB Group Recent Developments
  43. 8.8 Octapharma
  44. 8.8.1 Octapharma Company Information
  45. 8.8.2 Octapharma Business Overview
  46. 8.8.3 Octapharma Plasma for Fractionation Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Octapharma Plasma for Fractionation Product Portfolio
  48. 8.8.5 Octapharma Recent Developments
  49. 8.9 Hualan Bio
  50. 8.9.1 Hualan Bio Company Information
  51. 8.9.2 Hualan Bio Business Overview
  52. 8.9.3 Hualan Bio Plasma for Fractionation Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hualan Bio Plasma for Fractionation Product Portfolio
  54. 8.9.5 Hualan Bio Recent Developments
  55. 8.10 RAAS
  56. 8.10.1 RAAS Company Information
  57. 8.10.2 RAAS Business Overview
  58. 8.10.3 RAAS Plasma for Fractionation Revenue and Gross Margin (2021-2026)
  59. 8.10.4 RAAS Plasma for Fractionation Product Portfolio
  60. 8.10.5 RAAS Recent Developments
  61. 8.11 Takeda
  62. 8.11.1 Takeda Company Information
  63. 8.11.2 Takeda Business Overview
  64. 8.11.3 Takeda Plasma for Fractionation Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Takeda Plasma for Fractionation Product Portfolio
  66. 8.11.5 Takeda Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst